Skip to main content

Advertisement

Table 2 The serum levels of the hormones and metabolic profile, classified to 4 phenotypical groups and in non-PCOS women

From: The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran

Phenotype A (n = 11) B (n = 19) C (n = 42) D (n = 13) E (n = 517)
Variables AnOvu + HA + PCO AnOvu + HA HA + PCO AnOvu + PCO Normal
Testosterone (nmol/l) 0.4 ± 0.2 0.3 ± 0.4 0.2 ± 0.2 0.1 ± 0.1 0.1 ± 0.2
Androstendione (ng/ml) 3.7 ± 1.9 3.2 ± 2.1 2.0 ± 1.1 1.7 ± 0.7†‡ 1.4 ± 0.9
DHEAS (μg/dl) 205.7 ± 79.6 188.7 ± 93.4 161.2 ± 81.5 116.7 ± 52.1†‡ 119.7 ± 73.3
SHBG (nmol/l) 50.1 ± 39.62 49.7 ± 31.5 44.6 ± 30.2 54.4 ± 29.3 54.8 ± 34.9
FAI 2.8 ± 1.7 2.8 ± 2.6 2.3 ± 2.3 1.0 ± 1.0 1.2 ± 1.5
LH (μU/ml) 7.5 ± 5.9 7.8 ± 7.7 6.7 ± 5.4 6.0 ± 4.6 6.3 ± 5.9
FSH (μU/ml) 7.5 ± 1.17 8.4 ± 3.5 10.8 ± 12.0 8.3 ± 1.8 11.6 ± 10.0
Prolactin (ng/ml) 22.8 ± 12.0 19.9 ± 16.3 22.8 ± 15.3 23.4 ± 10.7 19.6 ± 20.0
TSH (μU/ml) 2.4 ± 1.3 2.4 ± 1.5 3.2 ± 2.7 1.8 ± 0.6 2.8 ± 2.7
Free T4 (picomol/l 15.7 ± 1.9 16.0 ± 3.4 15.7 ± 2.0 17.0 ± 2.6 15.5 ± 2.2
Insulin (μU/ml) 13.1 ± 10.6 7.7 ± 2.8 10.5 ± 13.0 5.7 ± 3.8†‡ 9.7 ± 9.4
HOMA-IR 3.1 ± 2.7 1.7 ± 0.7 2.1 ± 1.8 1.2 ± 0.9†‡ 2.5 ± 3.0
Cholesterol (mg/dl) 167.5 ± 35.8 159.4 ± 24.2 165.4 ± 40.2 156.5 ± 34.4 169.5 ± 34.4
HDL (mg/dl) 47.2 ± 9.8 49.4 ± 13.3 49.1 ± 11.0 46.4 ± 12.0 46.4 ± 11.9
LDL (mg/dl) 97.0 ± 30.5 89.2 ± 24.1 96.9 ± 39.2 93.1 ± 29.0 98.8 ± 29.5
Triglycerides (mg/dl) 116.3 ± 57.3 103.5 ± 49.5 98.0 ± 38.6 83.9 ± 40.1 122.6 ± 80.5
Glucose (mg/dl) 95.5 ± 7.8 94.1 ± 22.0 90.3 ± 11.8 87.5 ± 7.6 100.3 ± 48.0
  1. All analyses by ANCOVA adjusted for age and BMI.
  2. versus group E, P < 0.05.
  3. versus group A, P < 0.05.
  4. versus group C, P < 0.05.